Celltrion | 068270 - Equity Capital And Reserves


Celltrion reported KRW434.82B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 25.02M 2.36M Jun/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
Avita Medical AUD -16.65M 3.76M Dec/2025
Celltrion KRW 434.82B 1.14B Mar/2026
Dianthus Therapeutics USD 1.17B 29.29M Jun/2026
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
IQVIA Holdings USD 6.17B 50M Jun/2026
Moderna USD 6.76B 647M Jun/2026
Organon & Co USD 903M 151M Mar/2026
Revvity USD 7.18B 67.62M Mar/2026
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Viatris USD 14.26B 397.3M Jun/2026
Xeris Pharmaceuticals USD -9.73M 22.74M Jun/2026